Miscibility Behavior and Formation Mechanism of Stabilized Felodipine-Polyvinylpyrrolidone Amorphous Solid Dispersions
暂无分享,去创建一个
Evangelos Karavas | A. Xenakis | Emmanouel Georgarakis | Aristotelis Xenakis | E. Karavas | Georgios Ktistis | G. Ktistis | E. Georgarakis
[1] A. Juppo,et al. Evaluation of controlled-release polar lipid microparticles. , 2002, International journal of pharmaceutics.
[2] D. Craig,et al. The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.
[3] H. Kristensen,et al. The effect of α-tocopherol on the in vitro solubilisation of lipophilic drugs , 2001 .
[4] G Zografi,et al. How does residual water affect the solid-state degradation of drugs in the amorphous state? , 1996, Journal of pharmaceutical sciences.
[5] S. Srčič,et al. SOME PHYSICOCHEMICAL PROPERTIES OF GLASSY FELODIPINE , 1991 .
[6] Ying Ku Lin,et al. Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[7] H. Colom,et al. A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. , 1991, Journal of pharmaceutical sciences.
[8] Anant Paradkar,et al. Characterization of curcumin-PVP solid dispersion obtained by spray drying. , 2004, International journal of pharmaceutics.
[9] Dimitrios N. Bikiaris,et al. Hydrophilic matrices as carriers in felodipine solid dispersion systems , 2001 .
[10] B. Abrahamsson,et al. Evaluation of Solubilizers in the Drug Release Testing of Hydrophilic Matrix Extended-Release Tablets of Felodipine , 1994, Pharmaceutical Research.
[11] C. Regårdh,et al. Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients. , 1987, Clinical and investigative medicine. Medecine clinique et experimentale.
[12] F. Ponce-Gordo,et al. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. , 2004, International journal of pharmaceutics.
[13] D. Giron. Impact of Solid State Reactions on Medicaments , 1988 .
[14] A. Juppo,et al. Evaluation of polar lipid-hydrophilic polymer microparticles. , 2003, International journal of pharmaceutics.
[15] D. A. Shapiro,et al. Extended‐release felodipine in patients with mild to moderate hypertension , 1994, Clinical pharmacology and therapeutics.
[16] P. Parrini,et al. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. , 1999, Drug development and industrial pharmacy.
[17] N A Peppas,et al. Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[18] E. Squillante,et al. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. , 2004, International journal of pharmaceutics.
[19] J. Ford. The use of Thermal Analysis in the Study of Solid Dispersions , 1987 .
[20] George Zografi,et al. Physical Properties of Solid Molecular Dispersions of Indomethacin with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl-acetate) in Relation to Indomethacin Crystallization , 1999, Pharmaceutical Research.
[21] A. Serajuddin,et al. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.
[22] Ž. Knez,et al. Micronization of drugs using supercritical carbon dioxide. , 1999, International journal of pharmaceutics.
[23] S. Srčič,et al. Investigation of felodipine polymorphism and its glassy state , 1992 .
[24] B. Edgar,et al. Bioavailability from felodipine extended-release tablets with different dissolution properties , 1990 .
[25] C. Panayiotou,et al. Blends of polymers with similar glass transition temperatures: A DMTA and DSC study , 2004 .
[26] Keiji Sekiguchi,et al. Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man. , 1961 .
[27] D. Horn,et al. Chromatographic study of interactions between polyvinylpyrrolidone and drugs. , 1982, Journal of pharmaceutical sciences.
[28] Bruno C. Hancock,et al. The Relationship Between the Glass Transition Temperature and the Water Content of Amorphous Pharmaceutical Solids , 1994, Pharmaceutical Research.
[29] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[30] Margarita Valero,et al. Effect of PVP K-25 on the formation of the naproxen:β-ciclodextrin complex , 2003 .
[31] Björn Lemmer,et al. Circadian rhythms and drug delivery , 1991 .
[32] T. Fox. Influence of Diluent and of Copolymer Composition on the Glass Temperature of a Poly-mer System , 1956 .
[33] P Augustijns,et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[34] L Yu,et al. Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.